ApoA-1 in Diabetes: Damaged Goods

Overview

Journal Diabetes

Specialty Endocrinology

Date 2010 Sep 30

PMID 20876728

Citations 5

Authors

Daniel S Ory

Jean E Schaffer

Affiliations

Soon will be listed here.

Citing Articles

Metabolic labeling unveils alterations in the turnover of HDL-associated proteins during diabetes progression in mice.

Sadana P, Edler M, Aghayev M, Arias-Alvarado A, Cohn E, Ilchenko S Am J Physiol Endocrinol Metab. 2022; 323(6):E480-E491.

PMID: 36223521 PMC: 9722254. DOI: 10.1152/ajpendo.00158.2022.

Prospection of plasma proteins as biomarkers for diabetes mellitus monitoring.

de Paula Silva L, Gomes de Moraes Rego F, Picheth G, Muller-Santos M, Alberton D J Diabetes Metab Disord. 2021; 20(1):611-620.

PMID: 34222081 PMC: 8212233. DOI: 10.1007/s40200-021-00788-1.

Rapid degradation of ABCA1 protein following cAMP withdrawal and treatment with PKA inhibitor suggests ABCA1 is a short-lived protein primarily regulated at the transcriptional level.

Srivastava N, Cefalu A, Averna M, Srivastava R J Diabetes Metab Disord. 2020; 19(1):363-371.

PMID: 32550187 PMC: 7271302. DOI: 10.1007/s40200-020-00517-0.

Administration of CORM-2 inhibits diabetic neuropathy but does not reduce dyslipidemia in diabetic mice.

Mendez-Lara K, Santos D, Farre N, Ruiz-Nogales S, Leanez S, Sanchez-Quesada J PLoS One. 2018; 13(10):e0204841.

PMID: 30286142 PMC: 6171880. DOI: 10.1371/journal.pone.0204841.

Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions.

Shao B, Pennathur S, Heinecke J J Biol Chem. 2012; 287(9):6375-86.

PMID: 22219194 PMC: 3307260. DOI: 10.1074/jbc.M111.337345.

References

Jaleel A, Henderson G, Madden B, Klaus K, Morse D, Gopala S . Identification of de novo synthesized and relatively older proteins: accelerated oxidative damage to de novo synthesized apolipoprotein A-1 in type 1 diabetes. Diabetes. 2010; 59(10):2366-74. PMC: 3279529. DOI: 10.2337/db10-0371. View

Shao B, Tang C, Heinecke J, Oram J . Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export. J Lipid Res. 2010; 51(7):1849-58. PMC: 2882738. DOI: 10.1194/jlr.M004085. View

Ceriello A, Quagliaro L, Piconi L, Assaloni R, Da Ros R, Maier A . Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment. Diabetes. 2004; 53(3):701-10. DOI: 10.2337/diabetes.53.3.701. View

Curtiss L, Valenta D, Hime N, Rye K . What is so special about apolipoprotein AI in reverse cholesterol transport?. Arterioscler Thromb Vasc Biol. 2005; 26(1):12-9. DOI: 10.1161/01.ATV.0000194291.94269.5a. View

Barter P, Nicholls S, Rye K, Anantharamaiah G, Navab M, Fogelman A . Antiinflammatory properties of HDL. Circ Res. 2004; 95(8):764-72. DOI: 10.1161/01.RES.0000146094.59640.13. View

Brownlee M . Biochemistry and molecular cell biology of diabetic complications. Nature. 2001; 414(6865):813-20. DOI: 10.1038/414813a. View

Houstis N, Rosen E, Lander E . Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006; 440(7086):944-8. DOI: 10.1038/nature04634. View

Daugherty A, Dunn J, Rateri D, Heinecke J . Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest. 1994; 94(1):437-44. PMC: 296328. DOI: 10.1172/JCI117342. View

Zhou H, Tan K, Shiu S, Wong Y . Increased serum advanced glycation end products are associated with impairment in HDL antioxidative capacity in diabetic nephropathy. Nephrol Dial Transplant. 2007; 23(3):927-33. DOI: 10.1093/ndt/gfm631. View

10.

Boemi M, Leviev I, Sirolla C, Pieri C, Marra M, James R . Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protect LDL from oxidation. Atherosclerosis. 2001; 155(1):229-35. DOI: 10.1016/s0021-9150(00)00556-6. View

11.

Duell P, Oram J, Bierman E . Nonenzymatic glycosylation of HDL and impaired HDL-receptor-mediated cholesterol efflux. Diabetes. 1991; 40(3):377-84. DOI: 10.2337/diab.40.3.377. View

12.

Mastorikou M, Mackness M, Mackness B . Defective metabolism of oxidized phospholipid by HDL from people with type 2 diabetes. Diabetes. 2006; 55(11):3099-103. DOI: 10.2337/db06-0723. View

13.

Han E, Muller F, Perez V, Qi W, Liang H, Xi L . The in vivo gene expression signature of oxidative stress. Physiol Genomics. 2008; 34(1):112-26. PMC: 2532791. DOI: 10.1152/physiolgenomics.00239.2007. View

14.

Ostrander D, Sparagna G, Amoscato A, McMillin J, Dowhan W . Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis. J Biol Chem. 2001; 276(41):38061-7. DOI: 10.1074/jbc.M107067200. View

15.

Rader D . Illuminating HDL--is it still a viable therapeutic target?. N Engl J Med. 2007; 357(21):2180-3. DOI: 10.1056/NEJMe0707210. View

16.

Nishikawa T, Edelstein D, Du X, Yamagishi S, Matsumura T, Kaneda Y . Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature. 2000; 404(6779):787-90. DOI: 10.1038/35008121. View

17.

Shao B, Cavigiolio G, Brot N, Oda M, Heinecke J . Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I. Proc Natl Acad Sci U S A. 2008; 105(34):12224-9. PMC: 2527893. DOI: 10.1073/pnas.0802025105. View

18.

Matsuura F, Wang N, Chen W, Jiang X, Tall A . HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathway. J Clin Invest. 2006; 116(5):1435-42. PMC: 1451209. DOI: 10.1172/JCI27602. View

19.

Cacicedo J, Benjachareowong S, Chou E, Ruderman N, Ido Y . Palmitate-induced apoptosis in cultured bovine retinal pericytes: roles of NAD(P)H oxidase, oxidant stress, and ceramide. Diabetes. 2005; 54(6):1838-45. DOI: 10.2337/diabetes.54.6.1838. View

20.

Turner R, Millns H, Neil H, Stratton I, Manley S, Matthews D . Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ. 1998; 316(7134):823-8. PMC: 28484. DOI: 10.1136/bmj.316.7134.823. View